Indications: adjunctive treatment of partial seizures with or without secondary generalization, adjunctive treatment of myoclonic seizures.

Cautions: Avoid sudden withdrawal, pregnancy, renal and hepatic impairments.

Contra-indications: hypersensitivity to levetiracetam or any component of the formulation, breast-feeding.

Side Effects: nausea, vomiting, dyspepsia, diarrhea, cough, drowsiness, asthenia, amnesia, ataxia, dizziness, headache, tremor, hyperkinesia, depression, insomnia, anxiety, anorexia, diplopia, rash, confusion, irritability, psychosis, suicidal ideation, leucopenia, pancytopenia, thrombocytopenia and alopecia.

Dose: adult and child over 12 years, body – weight over 50 kg, initially 500 mg twice daily, adjusted every 2 to 4 weeks, max.1.5 g twice daily.

Child and adolescent 4-18 years (12- 18 years for myoclonic seizures), body weight under 50 kg initially 10 mg/kg twice daily adjusted every 2 weeks, max.30 mg/kg twice daily.